Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies.

Vitamin D insufficiency/deficiency during pregnancy has been linked to increased risk of preeclampsia. Placenta dysfunction plays an important role in the pathogenesis of this pregnancy disorder. In this study, we tested the hypothesis that disturbed vitamin D metabolism takes place in preeclamptic placentas. Protein expressions of vitamin D binding protein (VDBP), 25-hydroxylase (CYP2R1), 1α-hydroxylase (CYP27B1), 24-hydroxylase (CYP24A1), and vitamin D receptor (VDR) were examined in placentas from normotensive and preeclamptic pregnancies. By immunostaining we found that in normal placenta VDBP, CYP24A1, and VDR expressions are localized mainly in trophoblasts, whereas CYP2R1 and CYP27B1 expressions are localized mainly in villous core fetal vessel endothelium. Protein expressions of CYP2R1 and VDR are reduced, but CYP27B1 and CYP24A1 expressions are elevated, in preeclamptic compared with normotensive placentas. Because increased oxidative stress is an underlying pathophysiology in placental trophoblasts in preeclampsia, we further determined whether oxidative stress contributes to altered vitamin D metabolic system in placental trophoblasts. Trophoblasts isolated from normal-term placentas were treated with hypoxic-inducing agent CoCl(2), and protein expressions of VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR were determined. We found that hypoxia-induced downregulation of VDBP, CYP2R1, and VDR and upregulation of CYP27B1 and CYP24A1 expressions were consistent with that seen in preeclamptic placentas. CuZnSOD expression was also downregulated in trophoblasts treated with CoCl(2). These results provide direct evidence of disrupted vitamin D metabolic homeostasis in the preeclamptic placenta and suggest that increased oxidative stress could be a causative factor of altered vitamin D metabolism in preeclamptic placentas.

[1]  P. Norman,et al.  Vitamin D and cardiovascular disease. , 2014, Circulation research.

[2]  M. Hewison,et al.  Vitamin D, the placenta and pregnancy. , 2012, Archives of biochemistry and biophysics.

[3]  J. Thorp,et al.  Vitamin D in pregnancy: current concepts , 2012, Current opinion in obstetrics & gynecology.

[4]  P. Holt,et al.  Maternal Serum Vitamin D Levels During Pregnancy and Offspring Neurocognitive Development , 2012, Pediatrics.

[5]  A. Awad,et al.  Vitamin D and Metabolic Syndrome Risk Factors: Evidence and Mechanisms , 2012, Critical reviews in food science and nutrition.

[6]  P. Jenum,et al.  Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring , 2011, Diabetes.

[7]  V. Lagishetty,et al.  Vitamin D metabolism and innate immunity , 2011, Molecular and Cellular Endocrinology.

[8]  M. Uskoković,et al.  Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[9]  G. Zinser,et al.  Mammary adipocytes bioactivate 25‐hydroxyvitamin D3 and signal via vitamin D3 receptor, modulating mammary epithelial cell growth , 2011, Journal of cellular biochemistry.

[10]  Jun Sun,et al.  Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways , 2011, Gastroenterology research and practice.

[11]  S. Carda,et al.  1α,25-Dihydroxycholecalciferol Induces Nitric Oxide Production in Cultured Endothelial Cells , 2011, Cellular Physiology and Biochemistry.

[12]  Chung S. Yang,et al.  Oxidative stress‐induced attenuation of thrombospondin‐1 expression in primary rat astrocytes , 2011, Journal of cellular biochemistry.

[13]  M. Longtine,et al.  Vitamin D effects on pregnancy and the placenta. , 2010, Placenta.

[14]  C. Camargo,et al.  A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. , 2010, The Journal of clinical endocrinology and metabolism.

[15]  C. Wagner,et al.  Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. , 2010, American journal of obstetrics and gynecology.

[16]  I. Bhan,et al.  First Trimester Vitamin D, Vitamin D Binding Protein, and Subsequent Preeclampsia , 2010, Hypertension.

[17]  N. Inagaki,et al.  The effect of hypoxia mimetic cobalt chloride on the expression of EC-SOD in 3T3-L1 adipocytes , 2010, Redox report : communications in free radical research.

[18]  T. Down,et al.  Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene , 2009, Journal of Biological Chemistry.

[19]  Z. Dvořák,et al.  Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines , 2009, Molecular and Cellular Endocrinology.

[20]  F. Larrea,et al.  Reproductive Biology and Endocrinology Open Access Calcitriol Affects Hcg Gene Transcription in Cultured Human Syncytiotrophoblasts , 2022 .

[21]  M. Holick,et al.  Maternal vitamin D deficiency increases the risk of preeclampsia. , 2007, The Journal of clinical endocrinology and metabolism.

[22]  Carly M. Kemmis,et al.  Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. , 2006, The Journal of nutrition.

[23]  M. Speeckaert,et al.  Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[24]  F. Azizi,et al.  Changes in calcium, 25(OH) vitamin D3 and other biochemical factors during pregnancy , 2006, Journal of endocrinological investigation.

[25]  M. Hayashi,et al.  Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells. , 2004, The Journal of endocrinology.

[26]  F. Larrea,et al.  Expression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. , 2002, The Journal of clinical endocrinology and metabolism.

[27]  M. Kilby,et al.  The Ontogeny of 25-Hydroxyvitamin D3 1α-Hydroxylase Expression in Human Placenta and Decidua , 2002 .

[28]  S. Walsh,et al.  Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. , 2001, Placenta.

[29]  F. Larrea,et al.  Identification of a 25-Hydroxyvitamin D3 1α-Hydroxylase Gene Transcription Product in Cultures of Human Syncytiotrophoblast Cells , 2000 .

[30]  F. Larrea,et al.  Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. , 2000, The Journal of clinical endocrinology and metabolism.

[31]  S. Handwerger,et al.  Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3. , 1994, Endocrinology.

[32]  M. Goldberg,et al.  Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. , 1994, The Journal of biological chemistry.

[33]  D. Bikle,et al.  Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. , 1989, Endocrinology.

[34]  G. Lester.  Cholecalciferol and placental calcium transport. , 1986, Federation proceedings.

[35]  H. DeLuca,et al.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. , 1979, Science.

[36]  Y. Weisman,et al.  1α, 25-Dihydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta , 1979, Nature.

[37]  R. Kumar,et al.  Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. , 1979, The Journal of clinical investigation.

[38]  J. Stockman.  Maternal Serum Vitamin D Levels During Pregnancy and Offspring Neurocognitive Development , 2013 .

[39]  P. Brannon.  Symposium 3: Vitamin D and immune function: from pregnancy to adolescence Vitamin D and adverse pregnancy outcomes: beyond bone health and growth , 2012 .

[40]  J. Fleet,et al.  Vitamin D and cancer: a review of molecular mechanisms. , 2012, The Biochemical journal.

[41]  D. Bikle.  Vitamin D regulation of immune function. , 2011, Vitamins and hormones.

[42]  J. Reichrath,et al.  Metabolism of vitamin D3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births. , 2007, Clinical and experimental obstetrics & gynecology.

[43]  M. Kilby,et al.  The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. , 2002, The American journal of pathology.